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doi:10.1016/j.jfma.2012.02.019Renal transplant patients have high risk for bladder cancer. The reactivation of BK virus is
common in renal transplant patients especially in the urinary tract. There was some evidence
suggesting that the reactivation of BK virus (BKV) in renal transplant patients may associate
with the development of bladder cancer. Here we demonstrated that a patient that had persis-
tent elevated BKV viruria (urine BKV DNA concentration more than 1011 copies/ml) after renal
transplantation. Then, bladder cancer was found in 13 months after kidney transplantation.
The urine BKV DNA concentration was detected by real-time PCR and the BKV DNA in the
bladder tumor was detected by PCR. BKV DNA was found in the marginal and central part of
the bladder tumor. After removal of the bladder cancer, the urine BKV viral load in this
patients dropped dramatically to <102 copies/ml. However, the urine viral load had increased
modestly to 106 copies/ml in 3 months after surgery. Since there is a close correlation between
the urine BK viral load and the presence of bladder cancer, we suggested that there might be
a causal relationship between the reactivation of BKV and the development of bladder cancer
in renal transplant patient.
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Figure 1 (A) Correlation of urine BKV DNA viral load and clinical course of bladder cancer surgery. (B) Gel photograph showing
167-bp amplicon of BKV. NZ negative control; PZ positive control; S1Z central zone of the tumor; S2Zmarginal zone of the
tumor.
374 W.-Y. Yin et al.A 39-year-old woman underwent cadaveric renal trans-
plantation in November 2005. After the transplantation,
the patient was given a drug regimen that consisted of
cyclosporin A, mycophenolic acid, and prednisolone. The
trough level of cyclosporin was adjusted to about
400e600 ng/mL in the 1st postoperative month,
300e500 ng/mL in the 1st half-year, and 200e300 ng/mL
thereafter. Quantitative real-time polymerase chain reac-
tion demonstrated that the patient’s urine was positive for
BK virus (BKV) DNA (Fig. 1A). In the year 2007, the urinary
BK viral load in this patient was persistently elevated for 1
year. In January 2008, due to persistent hematuria, bladder
cancer was detected, and transurethral curettage was done
in February 2008. After surgery, the urinary viral load
dropped to <102 copies/mL. Since April 2008, the urinary
BKV viral load increased modestly. We found the genome of
BKV by polymerase chain reaction in the bladder cancer
specimen from the central and marginal zone in this case
(Fig. 1B). The drop in BK viral load after tumor removal
indicated that high urine BK viral load came from the
bladder cancer. During the post-surgery period, the patient
was maintained on the same dose of immunosuppressant
and showed no occurrence of bladder cancer until now.
Bladder cancer is a common cancer in adults, but the
role of exposure to virus such as human papillomavirus or
polyomavirus in bladder cancer has been a controversial
subject. Since the urogenital tract is the main site of BKV
latency, BKV could transform cells based on in vitro
studies.1 It has been speculated that BKV could have
a potential role in bladder cancer development. In fact,
the prevalence and titer of antibodies to BKV was higher
in individuals with bladder cancer,2 and there is a higher
percentage of BKV genome present in patients with
bladder cancer compared to normal controls.3 However,
other studies failed to demonstrate the correlation of BKV
and bladder cancer.4 We speculated that although most of
the general population has been infected with BKV,
significant BKV reactivation with clinical manifestations is
mostly limited to immunocompromised patientsespecially renal transplant patients. It is already known
that BKV contributes to BKV-associated nephropathy,
hemorrhagic cystitis, and ureteral stenosis in renal
transplant patients. The incidence of bladder cancer is
around 2- to 4-fold in patients undergoing renal trans-
plantation and with impaired immune surveillance due to
medication. In addition, virus infection/reactivation such
as BKV could play a role, and in fact BKV genome with
large T-antigen has been found in bladder cancer from
renal transplant patients.5 In this case, we have specifi-
cally demonstrated that there is a close time correlation
between high urinary viral loads of BKV and the occur-
rence of bladder cancer.
Taking these facts together, our report suggests that BKV
may be a transforming agent particularly in renal transplant
patients. In addition, a thoughtful examination for bladder
cancer is critical in renal transplantation patients with
persistent elevated urine BKV viral load.
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